CAPRA, Franco
 Distribuzione geografica
Continente #
NA - Nord America 5.149
EU - Europa 3.853
AS - Asia 2.607
SA - Sud America 412
Continente sconosciuto - Info sul continente non disponibili 63
AF - Africa 46
OC - Oceania 3
Totale 12.133
Nazione #
US - Stati Uniti d'America 4.996
RU - Federazione Russa 1.186
SG - Singapore 1.053
GB - Regno Unito 955
CN - Cina 841
IE - Irlanda 362
BR - Brasile 325
SE - Svezia 321
IT - Italia 292
FR - Francia 209
FI - Finlandia 185
VN - Vietnam 182
HK - Hong Kong 175
DE - Germania 165
CA - Canada 80
KR - Corea 70
UA - Ucraina 68
BD - Bangladesh 61
TR - Turchia 41
IN - India 39
JP - Giappone 29
AR - Argentina 27
MX - Messico 21
PK - Pakistan 20
BE - Belgio 19
PL - Polonia 19
IQ - Iraq 17
ZA - Sudafrica 15
CO - Colombia 14
EC - Ecuador 14
ES - Italia 12
NL - Olanda 12
GT - Guatemala 11
ID - Indonesia 10
IR - Iran 9
PY - Paraguay 9
VE - Venezuela 9
AT - Austria 8
HN - Honduras 8
MA - Marocco 8
IL - Israele 7
SA - Arabia Saudita 7
CR - Costa Rica 6
JO - Giordania 6
TW - Taiwan 6
AE - Emirati Arabi Uniti 5
KE - Kenya 5
NG - Nigeria 5
PE - Perù 5
PH - Filippine 5
TT - Trinidad e Tobago 5
UZ - Uzbekistan 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BO - Bolivia 4
LT - Lituania 4
NI - Nicaragua 4
RO - Romania 4
TN - Tunisia 4
AL - Albania 3
CH - Svizzera 3
CW - ???statistics.table.value.countryCode.CW??? 3
GP - Guadalupe 3
GR - Grecia 3
LV - Lettonia 3
SI - Slovenia 3
SV - El Salvador 3
UY - Uruguay 3
AZ - Azerbaigian 2
CL - Cile 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EE - Estonia 2
EG - Egitto 2
ET - Etiopia 2
JM - Giamaica 2
LB - Libano 2
NO - Norvegia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PA - Panama 2
PR - Porto Rico 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
AM - Armenia 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BW - Botswana 1
CI - Costa d'Avorio 1
CU - Cuba 1
CY - Cipro 1
GD - Grenada 1
HT - Haiti 1
IS - Islanda 1
KG - Kirghizistan 1
KY - Cayman, isole 1
KZ - Kazakistan 1
Totale 12.067
Città #
Southend 733
Ashburn 694
Singapore 611
Jacksonville 555
Dallas 471
Chandler 419
Moscow 391
Dublin 362
San Jose 357
Woodbridge 310
Ann Arbor 232
Houston 195
Hong Kong 172
The Dalles 122
Council Bluffs 99
Verona 98
Jinan 75
Wilmington 75
Beijing 73
New York 73
Los Angeles 68
Lawrence 65
Princeton 65
Ho Chi Minh City 61
Shenyang 55
Nanjing 54
Tianjin 49
Hebei 47
Hanoi 45
Munich 43
Lancaster 41
Buffalo 40
Helsinki 40
Nanchang 34
Santa Clara 33
Boardman 30
São Paulo 30
Tokyo 29
Annandale 28
Milan 27
Haikou 25
Philadelphia 25
Ningbo 23
Changsha 22
Hangzhou 22
London 22
Montreal 22
Columbus 21
Guangzhou 21
Rome 21
Taizhou 21
Turku 21
Brooklyn 19
Brussels 19
Zhengzhou 19
Sindelfingen 18
Strasbourg 18
Taiyuan 18
Seattle 17
Toronto 16
Detroit 15
Las Vegas 15
Chennai 14
Chicago 14
Auburn Hills 13
Falls Church 13
Rio de Janeiro 13
Johannesburg 12
Norwalk 12
Orem 12
Redondo Beach 12
Denver 11
Fuzhou 11
Haiphong 11
Warsaw 11
Guatemala City 10
Jiaxing 10
Karachi 10
Lanzhou 10
San Francisco 10
North Bergen 9
Redmond 9
Shanghai 9
Atlanta 8
Baghdad 8
Fairfield 8
Frankfurt am Main 8
Istanbul 8
Mexico City 8
Bologna 7
Boston 7
Calgary 7
Dhaka 7
Guarulhos 7
Leawood 7
Poplar 7
Redwood City 7
Amsterdam 6
Da Nang 6
Guayaquil 6
Totale 7.799
Nome #
Serum selenium in liver cirrhosis: correlation with markers of fibrosis 278
Iron and fibrogenesis in chronic viral hepatitis 277
Efficacy and safety of oral DAAs HCV therapy in the elderly 264
Chronic hepatitis in multiple virus infection: histopathological evaluation 258
Long-term variations of serum laminin and procollagen III peptide in chronic HCV hepatitis after alpha-interferon therapy 256
Decreased activity of scavenger enzymes in human hepatocellular carcinoma, but not in liver metastases 254
Serum laminin and type III procollagen in chronic hepatitis C. Diagnostic value in the assessment of disease activity and fibrosis 251
Acute hepatitis caused by green tea infusion: a case report 251
In vitro production of PNH-like red blood cells by 2-mercaptopropionylglycine 236
Acute hepatitis caused by green tea infusion: a case report . 236
Cortical adrenal activity in cirrhosis 233
Influenza del carico di ferro sulla fibrogenesi nei pazienti con epatite cronica da HCV 233
Effects on fibrogenesis markers of rheumatoid arthritis therapy with methotrexate 226
Serum laminin P1 in chronic viral hepatitis: Correlations with liver histological activity and diagnostic value 225
Efficacy and safety of DAA-based oral therapy i9n a large cohort of HCV patients treated in clinical practice in Italy and monitored by the NAVIGATORE web-platform. 224
Altered intestinal function precedes the appearance of bacterial DNA in serum and ascites in patients with cirrhosis. a pilot sutdy 221
Alpha-Interferon in the treatment of chronic viral hepatitis: effects on fibrogenesis serum markers 218
Cryoglobulinemia in hepatitis C virus chronic active hepatitis: Effects of interferon-alpha therapy 214
[Determination of HTLV-III-LAV antibodies in 2 different groups of heroin addicts in Verona in 1981 and 1985] 212
HCV-HGV infection: a clinico-therapeutic comparison with single HCV infection. 211
Altered intestinal function precedes the appearance of bacterial DNA in serum and ascites in patients with cirrhosis: A pilot study 209
Serum copper and ceruloplasmin in early and in advanced hepatocellular carcinoma: diagnostic and prognostic relevance 208
Clinical efficiency of recombinant activated factor VII (rFVIIa) during acute bleeding episode and surgery in a patient with high inhibitor titer. 208
[Plasma dehydroepiandrosterone sulfate and urine steroid excretion in hepatic cirrhosis] 207
Incidence and pattern of "de novo"hepatocellular carcinoma in HCV patients treated with oral DAAs, 204
HGV infection in a cohort of patients with chronic active hepatitis HCV related [3] 203
Selenium in liver diseasas: correlation with liver function 200
Liver resection for multinodular hepatocellular carcinoma. Lesson learn from observational study on 464 patients. 197
Beneficial effects of DAAs on cardiac function and structure in hepatitis C patients with low-moderate liver fibrosis 197
Pancolitis with ischemic injury as a complication of immunosuppressive treatment in a patient with autoimmune hepatitis: a case report. 188
Sofosbuvir plus ribavirin for difficult to treat HCV-2: improved efficacy with extended treatment duration. 188
Fibronectin is related to prealbumin in plasma of decompensated cirrhotics 187
Chronic hepatitis in multiple virus infection: histopatological evaluation. 182
[Therapy of idiopathic thrombocytopenic purpura: the role of human immunoglobulins] 180
Role of iron load on fibrogenesis in chronic hepatitis C 177
Plasma osteocalcin levels in liver cirrhosis 177
Drug-induced anti-factor VIII antibodies: A systematic review. 176
High serum calcitonin levels in heroin addicts 173
Is the liver resection justified in advanced hepatocellular carcinoma? Results of an observational study in 464 patients. 173
Intravenous immunoglobulins as pre-operative management in a case of hereditary spherocytosis 172
Riduzione della emocateresi splenica mediante alte dosi di immunoglobuline in un caso di sferocitosi ereditaria 170
PEG-interferon and ribavirin in HCV-related cirrhotic patients with profound thrombocytopenia. 166
Survival rate, prognostic factors and economical aspects in patients with intestinal failure 165
The natural history of chronic hepatitis C in a cohort of HIV negative Italian patients with hereditary bleeding disorders 162
Serum level of sICAM-1 in patients with HCV related chronic active hepatitis: a prognostic marker for responses to interferon treatment 161
Procollagen III peptide and fibronectin in alcohol-related chronic liver disease: correlations with morphological features and biochemical tests 154
Serum laminin and type III procollagen in chronic hepatitis C: Diagnostic value in the assessment of disease activity and fibrosis 153
Quelle due o tre tazze di tè verde: caso clinico. 153
Surgical versus non surgical therapy of HCC on cirrhosis: results of an observational study of 692 cases 152
Ipertensione portale e sue complicanze: emorragia da varici esofagee e sindrome epatorenale. Stato dell'arte. Moderatore seconda sessione 146
Interferon and ribavirin in HIV-negative haemophiliacs with chronic hepatitis C who were non responders to a previous interferon treatment. 143
Pulmonary mucosa-associated lymphoid tissue lymphoma and myasthenia gravis. A case report. 142
Prevalence of serum cryoglobulin in Italian haemophilic patients with hepatitis C virus infection. 140
The uptake of 3H-choline by paroxysmal nocturnal haemoglobinuria red blood cells, reticulocytes and energy depleted erythrocytes 139
Treatment of hepatitis C in hemophiliacs. 137
Hepatitis C in hemophiliacs 128
Vanishing bile duct syndrome and inflammatory pseudotumor associated with a case of anabolic steroid abuse 126
Retreatment of HCV related chronic hepatitis in non responders to interferon monotherapy: forecast and evaluation of the results. 126
Relationship between ABO blood group and Von Willebrand factor levels: from biology to clinical implications. 121
Nonresponse to interferon monotherapy in HCV-related chronic hepatitis: resultsof retreatment and prognostic factors. 118
Is Liver Resection Justified in Advanced Hepatocellular Carcinoma? Results of an Observational Study in 464 Patients 117
The effect of iron depletion on chronic hepatitis C virus infection. (Review) 115
L'epatite C negli emofilici. 110
Is liver resection justified in advanced hepatocellular carcinoma? Results of an observational study in 464 patients. 110
Menorrhagia and inherited disorders of coagulation. 98
Relationship between ABO blood groups and von Willebrand factor levels: from biology to clinical implications. [Review] 97
Totale 12.133
Categoria #
all - tutte 35.598
article - articoli 28.165
book - libri 0
conference - conferenze 6.362
curatela - curatele 0
other - altro 462
patent - brevetti 0
selected - selezionate 0
volume - volumi 609
Totale 71.196


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022317 0 0 0 0 30 16 16 31 20 19 55 130
2022/20231.362 105 130 104 223 89 486 5 70 105 4 27 14
2023/2024471 35 49 32 48 66 64 15 46 4 11 65 36
2024/20251.461 111 107 58 230 97 64 105 67 153 78 111 280
2025/20264.159 307 339 340 641 956 294 404 198 269 216 108 87
2026/2027801 45 105 192 439 20 0 0 0 0 0 0 0
Totale 12.133